25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance)
Katherine Van Loon(University of California, San Francisco), Alan P. Venook(University of California, San Francisco), Mary F. Mulcahy(Northwestern University), Federico Innocenti(AbbVie (United States)), Charles S. Fuchs(University of Southern California), Donna Niedzwiecki(Duke University), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Hedy L. Kindler(University of Chicago), Chen Jiang, Kouros Owzar(Duke University)
Cited by 38
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k